GLP-1 hair loss drives UK scalp agenda as minoxidil demand holds firm

Analysis

The week's dominant story is pharmacological: a new study links GLP-1 weight-loss drug use to hair loss in some men, including male-pattern balding and shedding ^[1][2][3]. Coverage moved quickly from research write-ups to consumer service journalism, with British GQ publishing a guide on how to tackle GLP-1 hair loss ^[4] and the Guardian running a broader explainer separating science from hype around weight-loss jabs, covering everything from "Ozempic breath" to hair loss ^[5]. For UK beauty and pharmacy retail, this is a fast-forming customer segment arriving with a specific, medically framed concern — and one that brands should expect to be asked about at the counter.

Search data suggests the treatment conversation is already skewing towards actives rather than general remedies. In the UK over the last three months, 'minoxidil' averaged 65/100 search interest, registering 63/100 in the week of 7 September, far ahead of 'dandruff shampoo' at 12/100 average (9/100 that week) and 'hair loss treatment' at 9/100 average (8/100) ^[6][7][8]. Good Housekeeping fed that demand with trichologist Anabel Kingsley's guidance on the best way to treat thinning hair with minoxidil ^[9].

Elsewhere, social discovery remains dominated by low-cost DIY: 'Rosemary Oil Hair Growth' videos published in the past fortnight drew 22,427,446 views across ten videos, versus 5,910,841 for 'Hair Loss Treatment' and just 166,910 for 'Scalp Massager Tutorial' ^[10][11][12]. Devices are gaining editorial support, with dermatologists recommending red light therapy tools for hair growth ^[13]. On launches, SENSAI has entered hair and scalp care ^[14]. The BBC covered cancer survivors living with chemo hair loss ^[15], while Louise McSharry shared regrowth tips ^[16].